Investing
American Rare Earths Limited (ARR:AU) has announced Successful Completion-Impurity Removal Neutralization Tests Download the PDF here. This post appeared first on investingnews.com
Connect with us
Hi, what are you looking for?
Investings Strategist
- Stock
Chart Mania – 23 ATR Move in QQQ – Metals Lead 2025 – XLV Oversold – XLU Breakout – ITB Moment of Truth
S&P 500 Breaking Out Again: What This Means for Your Portfolio
Momentum Leaders Are Rotating — Here’s How to Find Them
Is META Breaking Out or Breaking Down?
A Wild Ride For the History Books: 2025 Mid-Year Recap
- Investing
Successful Completion-Impurity Removal Neutralization Tests
Locksley Resources LimitedQualifies for Trading on U.S. OTCQX Market
Locksley Qualifies for Trading on U.S. OTCQX Market
Successful A$4.5m Two Tranche Placement
Editor’s Picks: Historic Week — Gold Breaks US$4,000, Silver Takes Out All-time High
- Economy
UPS is ‘disposing of’ U.S.-bound packages over customs paperwork problems
China outlines more controls on exports of rare earths and technology
Paramount acquires Bari Weiss’ The Free Press, naming her the top editor of CBS News
YouTube to pay $24 million to settle Trump lawsuit
Charlie Javice sentenced to 7 years in prison for fraudulent $175M sale of aid startup
- Politics
American creating deepfakes targeting Harris works with Russian intel, documents show
Early voting in Wisconsin slowed by label printing problems
Trump’s exaggerated claim that Pennsylvania has 500,000 fracking jobs
Tucker Carlson says father Trump will give ‘spanking’ at rowdy Georgia rally
A GOP operative accused a monastery of voter fraud. Nuns fought back.
Investing
Perth, Australia (ABN Newswire) – OTC Markets Group Inc. (OTCMKTS:OTCM), operator of regulated markets for 12,000 U.S. and international securities, today announced that Locksley...
Investing
Locksley Resources (LKY:AU) has announced Locksley Qualifies for Trading on U.S. OTCQX Market Download the PDF here. This post appeared first on investingnews.com
Investing
Green Technology Metals (GT1:AU) has announced Successful A$4.5m Two Tranche Placement Download the PDF here. This post appeared first on investingnews.com
Investing
It’s been yet another historic week for gold, as well as silver. Gold broke through US$4,000 per ounce midway through the period, entering never-before-seen...
Investing
Investing
Forte Minerals Corp. (‘Forte’ or the ‘Company’) (CSE:CUAU)(OTCQB:FOMNF)(Frankfurt:2OA) is pleased to announce its strategic engagement with Stockworks Agency Inc. (‘Stockworks’) as an investor relations...
Investing
Hertz Energy Inc. (CSE: HZ) (OTCQB: HZLIF) (FSE: QE2) (‘Hertz‘ or the ‘Company’) is pleased to announce the acquisition of the Harriman Antimony Property...
Investing
Los Andes Copper Ltd. (TSXV: LA) (OTCQX: LSANF) (‘Los Andes’ or the ‘Company’) is pleased to announce that its CEO, Santiago Montt, has been...
Investing
She emphasized that a global perspective is key for understanding these metals as geopolitical turmoil unfolds. ‘I think the incredible rise — meteoric rise...
Investing
OpenAI’s ChatGPT is one of the latest technological breakthroughs in the artificial intelligence space. But what is ChatGPT, and can you invest in OpenAI?...
Investing
ChemX Materials (ASX:CMX) (ChemX or the Company), an Australian high purity critical materials company and 100%-owner of the HiPurA® patented process to produce High...
Investing
Arcadium Lithium (NYSE:ALTM,ASX:LTM) announced on Wednesday (September 4) that it will place its Mount Cattlin spodumene operation in Western Australia on care and maintenance...
Investing
Description The securities of Galan Lithium Limited (‘GLN’) will be placed in trading halt at the request of GLN, pending it releasing an announcement....
Investing
Tartana Minerals Limited (ASX: TAT) (the Company), is pleased to advise that it has upgraded its Nightflower Exploration Target after reviewing its earlier estimation...
Investing
Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is pleased to confirm the commencement of U.S. clinical trials for its...
